ZFA-Logo

Vitamin C Reduces Incidence of Acute Kidney Failure After Contrast Medium

german translation / full article

A systematic review with meta-analysis of randomized controlled trials compared the use of ascorbic acid with placebo or other treatment options for thrapy of contrast induced-acute kidney injury (CI-AKI) in patients undergoing coronary angiography. Nine randomized, controlled trials reported data on the incidence of CI-AKI in 1,536 patients who had completed the trial and were included in the final analysis. Patients receiving ascorbic acid had 33% less risk of CI-AKI compared with patients receiving placebo or an alternate pharmacological treatment.


(State: 11.12.2014)

Latest Issue 11/2020

In Focus

  • How Useful is the Examination of Complete Blood Count in Healthy Adults?
  • Measurement of Glucose: Serum versus Plasma
  • Quality Management in Outpatient Teaching Practices